Simcere Zaiming sells 30,000 NextCure shares for $184,800
NXTC•Simcere Zaiming sells NextCure shares
- Simcere Zaiming sold 30,000 NextCure common shares on Aug. 10, 2026 at $6.16.
- Beneficial ownership fell to 308,636 shares following the sale.
- The filing marked an exit from Section 16 reporting after the group dropped below a 10% stake.
